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There has been recent clinical interest in this entity 
because of possible associations with supraventricular 
arrhythmias, sudden death and right-sided venous 
obstruction. 
Lipomatous atria1 septal hypertrophy is character- 
ized by deposition of excessive adipose tissue in the 
atria1 septum; the result is a globular thickening of the 
septum. Mature adipose cells mixed with granular or 
vacuolated fetal fat cells-the hallmark of lipomatous 
hypertrophy-infiltrate the myocardial fibers. In a se- 
ries of 32 autopsy specimens reported by McAllister 
and Fenoglio,3 the maximal diameter ranged from 1 to 
8 cm. 
Two-dimensional echocardiography is the tech- 
nique of choice for the diagnosis of this entity. The 
subcostal transducer position is considered the best. A 
bilobed atria1 septum with a thickness of at least 15 mm 
is highly characteristic of lipomatous hypertrophy. In 
our previous report of 17 patients with this entity, the 
average thickness of the atria1 septum was 21 mm 
(range 15 to 29j.l 
Because cardiac imaging with magnetic resonance 
is still in its infancy, few cases of atria1 septal hypertro- 
phy have been reported.4 The intensity of cardiac tis- 
sue in magnetic resonance images depends on spin 
density, relaxation times (Tl and T2) and cardiac mo- 
tion. The cardiac chambers are clearly differentiated 
from the myocardium because of the low intensity of 
flowing blood. This capability, as well as high intrinsic 
contrast between different soft tissues, allows accurate 
demonstration of the size and location of cardiac 
masses.5q6 Some degree of tissue characterization is 
possible on the basis of relative intensity alone. Fatty 
tissue is particularly different from other soft tissues 
because of its relaxation times and spin density. The 
Tl relaxation of fat is much shorter than that of other 
tissue, and the result is the high intensity in partial 
saturation spin-echo images. In these 2 patients, the 
magnetic resonance images substantiated the echocar- 
diographic diagnosis of lipomatous hypertrophy of the 
atria1 septum. Because the images were consistent with 
short spin-lattice relaxation times in the atria1 mass, 
the occurrence of a malignant process was much less 
likely, since malignancy generally prolongs relaxation 
times. 
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V asoactive peptides, termed atria1 natriuretic hor- 
mone (ANH), have been isolated from animal and hu- 
man atria1 tissue.* Serum levels of immunoreactive 
ANH have been reported to be elevated in pathophys- 
iologic conditions characterized by elevation of atria1 
pressure.2-5 Investigations have revealed a direct lin- 
ear correlation between ANH concentration and the 
magnitude of atria1 pressure in normal persons and in 
patients with heart failure.2s3 However, the mecha- 
From the Department of Internal Medicine, University of Mich- 
igan Medical Center, Ann Arbor, Michigan 48109-0366. This 
study was supported by Grant HL 18575 from the National 
Heart, Lung, and Blood Institute, Bethesda, Maryland. and the 
Research Service of the Veterans Administration, Washington, 
D.C. Manuscript received August 18. 1986; revised manuscript 
received September l&1986, accepted September 15, 1986. 
nism by which atria1 pressure mediates ANH secretion 
is unknown. We describe a case of cardiac tamponade 
in which hemodynamic recordings and ANH mea- 
surements were obtained during therapeutic pericar- 
diocentesis. From our observations we suggest that 
atria1 distention produced by changes in the pressure 
gradient across the atria1 wall is the major determinant 
of ANH release. 
A 42-year-old man presented with the sudden on- 
set of dull substernal chest pain. An electrocardiogram 
revealed an inferior wall acute myocardial infarction. 
Creatinine kinase levels increased to 4,800 W/liter 
with positive MB bands. On the third hospital day the 
patient had new, sharp, substernal chest pain that in- 
creased with inspiration and recumbency, and a new 
pericardial friction rub was heard on auscultation. 
The paradoxical pulse pressure was 14 mm Hg. The 
electrocardiogram did not reveal new ST-segment 
changes. The patient’s symptoms subsided and he was 
discharged on the 10th hospital day. 
The patient returned to the emergency room 3 days 
later with increased sharp substernal chest pain. The 
paradoxical pulse pressure had increased to 25 mm 
Hg. Heart sounds were normal except for an 54 gallop 
and the friction rub was no longer audible. Jugular 
venous distention was observed. The chest x-ray 
showed an enlarged cardiac silhouette relative to pre- 
vious studies, but the electrocardiogram was un- 
changed. An echocardiogram showed a large circum- 
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TABLE I Hemodynamic and Atrial Natriuretic Hormone 
Measurements Before and After Pericardiocentesis 
After 
Heart rate (baatslmin) 





Systemic artery (s/d) 140/100 1521102 160/100 
Right atrial mean 25 19 16 
Pulmonary artery (s/d) 44129 43125 43125 
Pulmonary artery wedge mean 24 15 17 
lntrapericardial pressure 23 19 
ANH (pmollliter) 13.9 112 69 
ANH = atrial natriuretic hormone; s/d = peak systolelend diastole. 
ferential pericardial effusion. A pulmonary artery 
(Swan-Ganz) catheter was placed and revealed eleva- 
tion and equalization of right atrial, right ventricular 
end-diastolic and pulmonary artery occlusion wedge 
pressures (Table I). The right atrial pressure tracing 
revealed absence of a significant y descent. Blood sam- 
ples were taken from the right atrial lumen for ANH 
determinations. ANH concentrations drawn 30 min- 
utes and immediately before pericardiocentesis were 
13 and 9 pmovliter, respectively (normal: mean 18 f 2 
pmovliter; range 3 to 30; n = 31). Bedside pericardio- 
centesis was then performed and 540 ml of noncoagu- 
lable hemorrhagic fluid was withdrawn. The paradox- 
ical pulse pressure after pericardiocentesis decreased 
to 14 mm Hg, with similar decreases in right atrial and 
pulmonary capillary wedge pressures. The right atrial 
pressure tracing showed appearance of a significant y 
descent. A subsequent echocardiogram showed a re- 
duced but persistent pericardial effusion. Left atrial 
dimension increased from 43 mm to 47 mm. Plasma 
ANH increased to 212 pmoVliter immediately after 
pericardiocentesis and remained elevated 1 hour af- 
terward, at 68 pmol/liter. 
This report describes a case of pericardial tampon- 
ade in which paradoxically reduced plasma ANH 
levels were found despite elevated right atria1 and 
pulmonary capillary wedge pressures. During pericar- 
diocentesis, reduction of these pressures was associ- 
ated with a significant elevation in ANH concentra- 
tion. These observations are in contrast to studies 
showing a direct correlation between plasma ANH 
concentration and atria1 pressure. Clinical conditions 
characterized by increased atria1 pressure, such as 
congestive heart failure and chronic renal failure with 
fluid overload, are associated with elevated levels of 
ANH.2-5 Rapid infusions of saline solution have pro- 
duced increases in ANH levels corresponding to atria1 
pressure elevations.6 Hemodynamic measurements in 
normal persons and patients with congestive heart 
failure have revealed a linear relation between ANH 
concentration and atria1 pressure.2-4 
The common factor apparently underlying the 
changes in ANH seen both after pericardiocentesis for 
cardiac tamponade and during acute or chronic extra- 
cellular fluid overload states is atria1 distention. The 
decompression and reexpansion of the atrium during 
pericardiocentesis may provide the stimulus for ANH 
release, as suggested by the present case. In saline 
solution infusion and chronic congestive heart failure, 
the increase in extracellular fluid volume produces an 
increase in atria1 pressure, leading to atria1 dilation. 
Chronic mitral stenosis and car pulmonale, conditions 
marked by enlargement of the left and right atria, re- 
spectively, are associated with significant ANH eleva- 
tions.3 ANH is also elevated during atrioventricular 
nodal tachycardia, in which near-simultaneous atria1 
and ventricular contractions result in elevated atria1 
pressure as the atrium contracts against a closed atrio- 
ventricular valvee2 Thus, ANH secretion is apparently 
associated with atria1 distention, either from dilation 
due to elevated intraatrial pressure or from pericardial 
decompression with an increase in the pressure gradi- 
ent across the atria1 wall. What role atria1 stretch re- 
ceptors have in this response may be a useful area for 
further investigation. 
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